Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer
Status:
Active, not recruiting
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine if we can identify the first lymph node
that drains from the tumor, and thus would be the most likely site for metastatic disease,
and remove it for analysis to improve the ability to detect tumor in this node and to remove
this additional site that potentially contains tumor cells.
Phase:
Phase 1
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Beth Israel Deaconess Medical Center Brigham and Women's Hospital Massachusetts General Hospital